Abstract
During fluorescence in situ hybridization (FISH) analysis of metaphase cells from 70 patients with lymphoid and myeloid hematologic malignancies and chromosomal rearrangements involving band 12p13, we identified nine patients (four with lymphoid malignancies, four with myeloid malignancies and one with biphenotypic leukemia) who showed more complicated rearrangements than we had expected from conventional cytogenetic study. In six patients, multiple breaks occurred in small segments of 12p with subsequent translocations and insertions of these segments into other chromosomes, sometimes to unexpected regions. In three patients additional chromosome breaks resulted in a sub-clone which was cytogenetically indistinguishable from the main clone in each patient based on the cytogenetic analysis. These subtle molecular events were detected exclusively in a region covering TEL/ETV6 and KIP1/CDKN1B. Seven of nine had a previous history of chemo/radiotherapy; all the patients showed complex karyotypes, even though they were newly diagnosed with leukemia. Survival data were available in five patients, and all survived less than 6 months. These findings suggest that the 12p13 region, especially the above-mentioned region, is genetically unstable and fragile. It is likely that multiple chromosome breaks were induced through mutagens used in chemo/ radiotherapy, and are associated with a sub-group of patients with an extremely bad prognosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Raimondi SC, Shurtleff SA, Downing JR, Rubnitz J, Mathew S, Hancock M, Pui CH, Rivera GK, Grosveld GC, Behm FG . 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia Blood 1997 90: 4559–4566
Takeuchi S, Seriu T, Bartram CR, Golub TR, Reiter A, Miyoshi I, Gilliland DG, Koeffler HP . TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemia Leukemia 1997 11: 1220–1223
Andreasson P, Johansson B, Billstrom R, Garwicz S, Mitelman F, Hoglund M . Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements Leukemia 1998 12: 390–400
Wlodarska I, La Starza R, Baens M, Dierlamm J, Uyttebroeck A, Selleslag D, Mecucci C, Hagemeijer A, Van den Berghe H, Marynen P . Fluorescence in situ hybridization characterization of new translocation involving TEL (ETV6) in a wide spectrum of hematologic malignancies Blood 1998 91: 1399–1406
Rowley JD . The role of chromosomal translocations in leukemia Semin Hematol 1999 36: 59–72
Mitelman F . Catalog of Chromosome Aberrations in Cancer ‘98 Wiley-Liss: New York 1998
Golub TR, Barker GF, Lovett M, Gilliland DG . Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation Cell 1994 77: 307–316
Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG . Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia Mol Cell Biol 1996 16: 4107–4116
Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM . The novel activation of ABL by fusion to an ets-related gene, TEL Cancer Res 1995 55: 34–38
Iijima Y, Ito T, Oikawa T, Eguchi M, Eguchi-Ishimae M, Kamada N, Kishi K, Asano S, Sakaki Y, Sato Y . A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation Blood 2000 95: 2126–2131
Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P . Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia Blood 1997 90: 2535–2540
Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA . A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 1997 278: 1309–1312
Eguchi M, Eguchi-Ishimae M, Tojo A, Morishita K, Suzuki K, Sato Y, Kudoh S, Tanaka K, Setoyama M, Nagamura F, Asano S, Kamada N . Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25) Blood 1999 93: 1355–1363
Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH . A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma Nat Genet 1998 18: 184–187
Knezevich SR, Garnett MJ, Pysher TJ, Beckwith JB, Grundy PE, Sorensen PH . ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma Cancer Res 1998 58: 5046–5048
Rubin BP, Chen CJ, Morgan TW, Xiao S, Grier HE, Kozakewich HP, Perez-Atayde AR, Fletcher JA . Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma Am J Pathol 1998 153: 1451–1458
Romana SP, Mauchauffe M, Le CM, Chumakov I, Le PD, Berger R, Bernard OA . The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion Blood 1995 85: 3662–3670
Odero M, Carlson K, Calasanz M, Chinwalla V, Rowley J . Identification of eight new translocations involving TEL/ETV6 in hematological malignancies using FISH and spectral karyotyping Blood 1999 94: (Suppl. 1) 495a
Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Davis EM, Le Beau MM, Roberts JM, Vogelstein B, Rowley JD, Bohlander SK . TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies Blood 1995 86: 1525–1533
Baens M, Wlodarska I, Corveleyn A, Hoornaert I, Hagemeijer A, Marynen P . A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p) Genomics 1999 56: 40–50
Sato Y, Bohlander SK, Kobayashi H, Reshmi S, Suto Y, Davis EM, Espinosa III R, Hoopes R, Montgomery K, Kucherlapati R, Le Beau MM, Rowley JD . Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL(ETV6) is involved in only one half Blood 1997 90: 4886–4893
La Starza R, Stella M, Testoni N, Di BE, Ciolli S, Marynen P, Martelli MF, Mandelli F, Mecucci C . Characterization of 12p molecular events outside ETV6 in complex karyotypes of acute myeloid malignancies Br J Haematol 1999 107: 340–346
Wlodarska I, Marynen P, La Starza R, Mecucci C, Van den Berghe H . The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in a various 12p aberrations in different hematological malignancies Cytogenet Cell Genet 1996 72: 229–235
Le Beau MM . Cytogenetic analysis of hematological malignant diseases In: Barch MJ (ed.) The ACT Cytogenetics Laboratory Manual Raven Press: New York 1991 pp 395–445
Mitelman F . An International System for Human Cytogenetic Nomenclature S Karger: Basel 1995
Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C, Trask BJ, Roberts JM, Kinzler KW, Rowley JD, Vogelstein B . Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias Cancer Res 1995 55: 1206–1210
Kobayashi H, Montgomery KT, Bohlander SK, Adra CN, Lim BL, Kucherlapati RS, Donis-Keller H, Holt MS, Le Beau MM, Rowley JD . Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases Blood 1994 84: 3473–3482
Rowley JD, DÃaz MO, Espinosa R, Patel YD, van Melle E, Ziemin S, Taillon-Miller P, Lichter P, Evans GA, Kersey JH, Ward DC, Domer PH, Le Beau MM . Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome Proc Natl Acad Sci USA 1990 87: 9358–9362
Kobayashi H, Rowley JD . Identification of cytogenetically undetected 12p13 translocations and associated deletions with fluorescence in situ hybridization Genes Chromosomes Cancer 1995 12: 66–69
Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD . Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7 J Clin Oncol 1986 4: 325–345
Rowley JD . 1993 Robert R deVilliers Lecture. Chromosome translocations: dangerous liaisons Leukemia 1994 8: S1–S6
Marlton P, Claxton DF, Liu P, Estey EH, Beran M, LeBeau M, Testa JR, Collins FS, Rowley JD, Siciliano MJ . Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis Blood 1995 85: 772–779
Martinet D, Muhlematter D, Leeman M, Parlier V, Hess U, Gmur J, Jotterand M . Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML) Leukemia 1997 11: 964–970
Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green AR . Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia Blood 2000 95: 738–743
Godon C, Proffitt J, Dastuguc N, Lafage-Pochitaloff M, Talmani P, Hackbarth M, Bataille R, Avet-Loiscau H . Large deletions 5′ to ETO breakpoint were observed in 10% of patients with t(8;21)-positive AML Blood 2000 96: 691a
Tanaka K, Arif M, Eguchi M, Kyo T, Dohy H, Kamada N . Frequent jumping translocation of chromosomal segments involving the ABL oncogene alone or in combination with CD3-MLL genes in secondary leukemias Blood 1997 89: 596–600
Acknowledgements
We thank Marjorie Isaacson for gathering the data on these patients and Shalini Reshmi for technical assistance. This work was supported by a Grant-in-Aid for International Exchange from Japan Clinical Pathology Foundation (YS), NIH grants CA42557 (JDR) and CA40046 (JDR and MML), The Spastic Paralysis Foundation of the Illinois-Eastern Iowa District of Kiwanis International (JDR) and the G Harold and Leila Y Mathers Charitable Foundation (JDR).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sato, Y., Kobayashi, H., Suto, Y. et al. Chromosomal instability in chromosome band 12p13: multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clones. Leukemia 15, 1193–1202 (2001). https://doi.org/10.1038/sj.leu.2402188
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402188
Keywords
This article is cited by
-
Exosome-derived miR-200a promotes esophageal cancer cell proliferation and migration via the mediating Keap1 expression
Molecular and Cellular Biochemistry (2022)
-
MicroRNA and AU-rich element regulation of prostaglandin synthesis
Cancer and Metastasis Reviews (2011)
-
miR-200bc/429 cluster targets PLCγ1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer
Oncogene (2010)
-
Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia
Leukemia (2008)
-
Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
British Journal of Cancer (2003)